Volume 30, Number 5—May 2024
Research
Economic Burden of Acute Gastroenteritis among Members of Integrated Healthcare Delivery System, United States, 2014–2016
Table 2
EHR-derived measures | MAAGE cases, n = 8,558† | Comparators, N = 8,580 | p value‡ |
---|---|---|---|
Mean age, y (+SD) |
6.0 (5.2) |
6.3 (5.3) |
<0.001 |
Sex, % | |||
F | 47.0 | 47.1 | NA |
M |
53.0 |
52.9 |
NA |
Race/ethnicity, % | |||
Hispanic | 18.0 | 11.7 | <0.001 |
Non-Hispanic White | 63.5 | 70.2 | <0.001 |
Non-Hispanic other race | 15.0 | 14.3 | <0.001 |
Unknown |
3.5 |
3.8 |
<0.001 |
Comorbidity, %§ | |||
Blood disease | 0.7 | 0.6 | 0.384 |
Cancer | 0.2 | 0.3 | 0.547 |
Diabetes | 0.4 | 0.5 | 0.651 |
Heart disease | 1.4 | 1.5 | 0.524 |
Immune disease | 0.4 | 0.3 | 0.047 |
Kidney disease | 0.4 | 0.4 | 0.800 |
Liver disease | 0.02 | 0.03 | 0.655 |
Lung disease | 8.1 | 6.6 | <0.001 |
Metabolic disease | 0.7 | 0.8 | 0.528 |
Neurologic disease | 1.8 | 2.0 | 0.317 |
*All participants were Kaiser Permanente Northwest medical members, <18 y of age, with ≥1 encounter at the time of the study. EHR, electronic health records; NA, not applicable †Corresponds to 9,203 episodes; 834 MAAGE cases were comparators at some time in the study ‡Paired t-test or χ2 test. §Percentage with diagnosis codes from the International Classification of Diseases, 9th Revision or 10th Revision, in the 12 mo before index encounter date.
Page created: April 10, 2024
Page updated: April 23, 2024
Page reviewed: April 23, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.